4//SEC Filing
BUCHI J KEVIN 4
Accession 0001628280-24-023247
CIK 0001723128other
Filed
May 13, 8:00 PM ET
Accepted
May 14, 4:41 PM ET
Size
6.7 KB
Accession
0001628280-24-023247
Insider Transaction Report
Form 4
BUCHI J KEVIN
Director
Transactions
- Exercise/Conversion
Restricted Stock Units
2024-05-10−76,453→ 0 total→ Class A Common Stock (76,453 underlying) - Exercise/Conversion
Class A Common Stock
2024-05-10+76,453→ 262,072 total
Footnotes (2)
- [F1]Each restricted stock unit represents a contingent right to receive one share of the Issuer's Class A Common Stock.
- [F2]On May 9, 2023, the reporting person was granted 76,453 restricted stock units vesting on May 10, 2024.
Documents
Issuer
Amneal Pharmaceuticals, Inc.
CIK 0001723128
Entity typeother
Related Parties
1- filerCIK 0001209726
Filing Metadata
- Form type
- 4
- Filed
- May 13, 8:00 PM ET
- Accepted
- May 14, 4:41 PM ET
- Size
- 6.7 KB